Get the Stockscreener App
48.60
1.84%
-0.91
After Hours:
48.60
Disc Medicine Inc stock is traded at $48.60, with a volume of 291.20K.
It is down -1.84% in the last 24 hours and up +17.90% over the past month.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
See More
Previous Close:
$49.51
Open:
$47
24h Volume:
291.20K
Relative Volume:
0.73
Market Cap:
$1.60B
Revenue:
-
Net Income/Loss:
$-91.00M
P/E Ratio:
-13.24
EPS:
-3.67
Net Cash Flow:
$-74.38M
1W Performance:
+5.29%
1M Performance:
+17.90%
6M Performance:
-24.97%
1Y Performance:
+63.14%
1-Day Range:
$47.00
$50.40
1-Week Range:
$45.06
$50.66
52-Week Range:
$28.25
$68.73
Disc Medicine Inc Stock (IRON) Company Profile
Name
Disc Medicine Inc
Sector
Industry
Phone
(617) 674-9274
Address
321 ARSENAL STREET, SUITE 101, WATERTOWN
Compare IRON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
48.60 | 1.60B | 0 | -91.00M | -74.38M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-27-25 | Initiated | TD Cowen | Buy |
| Nov-05-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-04-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Oct-23-24 | Initiated | Jefferies | Buy |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Aug-22-24 | Initiated | Wells Fargo | Overweight |
| Apr-01-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-19-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-09-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jun-07-23 | Initiated | H.C. Wainwright | Buy |
| May-17-23 | Initiated | Raymond James | Outperform |
| Apr-28-23 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-21-23 | Initiated | Stifel | Buy |
| Apr-20-23 | Initiated | Morgan Stanley | Overweight |
| Mar-23-23 | Initiated | BMO Capital Markets | Outperform |
| Feb-28-23 | Initiated | SVB Securities | Outperform |
View All
Disc Medicine Inc Stock (IRON) Latest News
Invesco Ltd. Increases Stock Holdings in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Wells Fargo & Company MN Grows Position in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine to Host Webinar with Key Opinion Leaders on Anemia of Myelofibrosis (MF) - The Manila Times
Leading Cancer Centers Join Forces to Review Breakthrough Myelofibrosis Anemia Treatment Data - Stock Titan
JPMorgan Chase & Co. Purchases 44,762 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Renaissance Technologies LLC Makes New $5.48 Million Investment in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
When (IRON) Moves Investors should Listen - news.stocktradersdaily.com
Disc Medicine, Inc. (NASDAQ:IRON) Shares Sold by Geode Capital Management LLC - Defense World
New GlyT-1 inhibitors disclosed in Disc Medicine patent - BioWorld MedTech
Disc Medicine, Inc. (NASDAQ:IRON) Given Consensus Rating of “Buy” by Brokerages - Defense World
Disc Medicine price target raised to $132 from $99 at Cantor Fitzgerald - MSN
Vanguard Group Inc. Has $67.73 Million Stock Holdings in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine: Forging Ahead In Hematology (NASDAQ:IRON) - Seeking Alpha
3,700 Shares in Disc Medicine, Inc. (NASDAQ:IRON) Acquired by KLP Kapitalforvaltning AS - Defense World
Corebridge Financial Inc. Has $622,000 Position in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine, Inc.'s (NASDAQ:IRON) institutional investors lost 21% over the past week but have profited from longer-term gains - simplywall.st
Teacher Retirement System of Texas Increases Stake in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine is Now Oversold (IRON) - Nasdaq
Swiss National Bank Sells 2,600 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc medicine director Ashiya Mona sells shares worth $310,483 By Investing.com - Investing.com Canada
Orbimed advisors sells $310,483 in disc medicine stock By Investing.com - Investing.com Canada
Is Disc Medicine, Inc. (NASDAQ:IRON) the Best Small Cap Stock to Buy Before They Explode? - Insider Monkey
Orbimed advisors sells $310,483 in disc medicine stock - Investing.com India
Disc medicine director Ashiya Mona sells shares worth $310,483 - Investing.com India
10 Best Small-Cap Stocks to Buy Before They Explode - Insider Monkey
Raymond James Financial Inc. Purchases New Position in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
With 65% ownership, Disc Medicine, Inc. (NASDAQ:IRON) boasts of strong institutional backing - Yahoo
Disc Medicine, Inc. (NASDAQ:IRON) Shares Purchased by Charles Schwab Investment Management Inc. - Defense World
Ashiya Mona sells $2.83 million in Disc Medicine stock By Investing.com - Investing.com South Africa
OrbiMed Advisors sells $2.83 million in Disc Medicine stock By Investing.com - Investing.com Philippines
Orbimed Advisors LLC Reduces Stake in Disc Medicine Inc: Analyzi - GuruFocus
Ashiya Mona sells $2.83 million in Disc Medicine stock - Investing.com
OrbiMed Advisors sells $2.83 million in Disc Medicine stock - Investing.com
ORBIMED ADVISORS LLC Reduces Stake in Disc Medicine Inc - GuruFocus
(IRON) Trading Advice - news.stocktradersdaily.com
Disc Medicine, Inc. (NASDAQ:IRON) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Bank of New York Mellon Corp Buys 4,356 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine’s SWOT analysis: rare blood disorder biotech stock’s potential By Investing.com - Investing.com South Africa
Disc Medicine’s SWOT analysis: rare blood disorder biotech stock’s potential - Investing.com
Disc Medicine Inc Stock (IRON) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.39%
3.66%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):